The latest Ebola outbreak in Africa has claimed more than 5,300 lives, with the Democratic Republic of the Congo (DRC) remaining the primary epicentre of the crisis. According to the most recent data released by the Africa Centres for Disease Control and Prevention (Africa CDC) on Monday, the total death toll stands at 5,376. Of these fatalities, 5,372 occurred within the DRC, while two deaths each have been reported in Kenya and Uganda.
This marks the 17th, and notably the largest, Ebola outbreak the DRC has faced since it began in mid-May. The pathogen driving this health emergency is the rare Bundibugyo strain, which has proven particularly difficult to contain. Official records indicate that approximately 10,444 people have been infected across the DRC, Uganda, and Kenya, resulting in a staggering mortality rate that exceeds 50 percent.
The virus has displayed a significant capacity for cross-border transmission in recent months. Neighbouring Uganda previously registered 20 cases, primarily involving individuals who had travelled from the DRC, before health officials were able to declare the nation Ebola-free in August. More recently, Kenya reported its first-ever cases of the virus in October, which resulted in nine infections and two fatalities.
While the virus has travelled, not all suspected cases in the region have been confirmed. In Nigeria, which reported its first imported case in October, health authorities successfully conducted two rounds of testing on suspected patients in the northeast region, both of which returned negative results. Nigeria has not recorded any deaths related to this outbreak. Additionally, a single case was identified in France in July, involving a health worker who had returned from the DRC.
The challenge for medical responders is exacerbated by the lack of approved vaccines or established treatments specifically designed to target the Bundibugyo strain. Current clinical interventions are limited, though authorities have recently launched trials using the Ervebo vaccine. While this vaccine has demonstrated efficacy against the more common Zaire strain of the virus, its effectiveness against the current Bundibugyo variant is still being evaluated.
The containment efforts have faced severe logistical and security hurdles on the ground. Reports indicate that medical personnel remain at high risk; in one incident, attackers killed a nurse and injured a health worker who were actively responding to a confirmed Ebola case. Despite these dangers, workers continue to provide care in treatment centres, and there have been instances of recovery that provided rare moments of relief for the affected communities.
As the death toll continues to climb, international health bodies and local governments are closely monitoring border crossings to prevent further regional transmission. The Africa CDC data underscores the urgency of the situation, as the virus persists in areas with high mobility and complex public health infrastructure. For now, the focus remains on rigorous testing, contact tracing, and the ongoing clinical trials, as the continent works to halt the spread of the deadliest outbreak of this strain in history.
Comments